header image

Haematology

These plasma derived products are produced to the highest standards, using the latest technology, in state-of-the-art manufacturing facilities to ensure the most advanced therapies are available to patients globally. 

nuwiq

octanate

wilate

octanine F

nuwiq® (human coagulation factor VIII recombinant DNA, simoctocog alfa)

Human coagulation factor VIII (rDNA), Nuwiq® (simoctocog alfa) is a purified protein for the treatment and prophylaxis of bleeding in all age groups with haemophilia A (congenital factor VIII [FVIII] deficiency). The amino acid sequence is comparable to the 90 + 80 kDa form of human plasma factor VIII (i.e. B-domain deleted). Nuwiq® is produced by recombinant DNA technology in genetically modified human embryonic kidney (HEK) 293F cells. No animal or human derived materials are added during the manufacturing process or to the final medicinal product.

 

Powder and solvent for solution for injection available in vials of:

  • 250 IU
  • 500 IU
  • 1000 IU
  • 2000 IU

 

You are now on Octapharma’s global website. Please select your country from the menu to access more detailed country-specific information or to contact your local Octapharma team.

octanate®

High-purity human Factor VIII / von Willebrand Factor (VWF) concentrate for prophylaxis and treatment of bleeding in patients with haemophilia A. Octanate undergoes two independent virus-inactivation steps (solvent/detergent treatment and terminal dry heat for 30 minutes at 100°C).

 

Available in vials of:

  • 250 IU
  • 500 IU
  • 1000 IU

 

You are now on Octapharma’s global website. Please select your country from the menu to access more detailed country-specific information or to contact your local Octapharma team.

wilate®

High-purity human von Willebrand Factor (VWF)/Factor VIII concentrate with the native VWF/FVIII complex in physiological 1:1 ratio and two independent virus inactivation steps (solvent/detergent treatment and terminal dry heat at 100°C for 120 min) for the treatment of patients with von Willebrand disease (VWD) and haemophilia A.

 

Available in vials of:

  • 500 IU
  • 1000 IU

 

You are now on Octapharma’s global website. Please select your country from the menu to access more detailed country-specific information or to contact your local Octapharma team.

octanine®F

High-purity human Factor IX concentrate with two independant virus inactivation and removal steps (solvent/detergent treatment and nanofiltration) for the prophylaxis and treatment of bleeding in patients with haemophilia B.


Available in vials of:

  • 250 IU
  • 500 IU
  • 1000 IU

 

You are now on Octapharma’s global website. Please select your country from the menu to access more detailed country-specific information or to contact your local Octapharma team.